Search Results - "Ettcheto, Miren"

Metal-based nanoparticles as antimicrobial agents: an overview by Sánchez-López, Elena, Gomes, Daniela, Esteruelas, Gerard, Bonilla, Lorena, Lopez-Machado, Ana Laura, Galindo, Ruth, Cano, Amanda, Espina, Marta, Ettcheto, Miren, Camins, Antoni, Silva, Amélia M., Durazzo, Alessandra, Santini, Antonello, Garcia, Maria L., Souto, Eliana B.

“…Metal-based nanoparticles have been extensively investigated for a set of biomedical applications. According to the World Health Organization, in addition to…”
Get full text

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications by Folch, Jaume, Busquets, Oriol, Ettcheto, Miren, Sánchez-López, Elena, Castro-Torres, Ruben Dario, Verdaguer, Ester, Garcia, Maria Luisa, Olloquequi, Jordi, Casadesús, Gemma, Beas-Zarate, Carlos, Pelegri, Carme, Vilaplana, Jordi, Auladell, Carme, Camins, Antoni

“…Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence in the brain of extracellular amyloid-β protein (Aβ) and intracellular…”
Get more information

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization by Sánchez-López, Elena, Ettcheto, Miren, Egea, Maria Antonia, Espina, Marta, Cano, Amanda, Calpena, Ana Cristina, Camins, Antoni, Carmona, Nuria, Silva, Amélia M, Souto, Eliana B, García, Maria Luisa

“…Memantine, drug approved for moderate to severe Alzheimer's disease, has not shown to be fully effective. In order to solve this issue, polylactic-co-glycolic…”
Get full text

Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents by Souto, Eliana B, Dias-Ferreira, João, López-Machado, Ana, Ettcheto, Miren, Cano, Amanda, Camins Espuny, Antonio, Espina, Marta, Garcia, Maria Luisa, Sánchez-López, Elena

“…The eye presents extensive perspectives and challenges for drug delivery, mainly because of the extraordinary capacity, intrinsic to this path, for drugs to…”
Get full text

Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment by Camins, Antoni, Auladell, Carme, Olloquequi, Jordi, García, M. Luisa, Sánchez-López, Elena, Abad, Sonia, Ettcheto, Miren, Petrov, Dmitry, Folch, Jaume, Beas-Zarate, Carlos

“…Alzheimer’s disease (AD) currently presents one of the biggest healthcare issues in the developed countries. There is no effective treatment capable of slowing…”
Get full text

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges by Cano, Amanda, Turowski, Patric, Ettcheto, Miren, Duskey, Jason Thomas, Tosi, Giovanni, Sánchez-López, Elena, García, Maria Luisa, Camins, Antonio, Souto, Eliana B, Ruiz, Agustín, Marquié, Marta, Boada, Mercè

“…Increasing life expectancy has led to an aging population, which has consequently increased the prevalence of dementia. Alzheimer's disease (AD), the most…”
Get full text

Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders by Olloquequi, Jordi, Cano, Amanda, Sanchez-López, Elena, Carrasco, Marina, Verdaguer, Ester, Fortuna, Ana, Folch, Jaume, Bulló, Mònica, Auladell, Carme, Camins, Antoni, Ettcheto, Miren

“…Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered a direct negative regulator of several receptor and…”
Get full text

Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy by Cano, Amanda, Ettcheto, Miren, Espina, Marta, Auladell, Carmen, Calpena, Ana Cristina, Folch, Jaume, Barenys, Marta, Sánchez-López, Elena, Camins, Antoni, García, Maria Luisa

“…Temporal lobe epilepsy is the most common type of pharmacoresistant epilepsy in adults. Epigallocatechin-3-gallate has aroused much interest because of its…”
Get full text

Current applications of nanoemulsions in cancer therapeutics by Sánchez-López, Elena, Guerra, Mariana, Dias-Ferreira, João, Lopez-Machado, Ana, Ettcheto, Miren, Cano, Amanda, Espina, Marta, Camins, Antoni, Garcia, Maria Luisa, Souto, Eliana B.

“…Nanoemulsions are pharmaceutical formulations composed of particles within a nanometer range. They possess the capacity to encapsulate drugs that are poorly…”
Get full text

Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice by Ettcheto, Miren, Cano, Amanda, Manzine, Patricia R., Busquets, Oriol, Verdaguer, Ester, Castro-Torres, Rubén Dario, García, Maria Luisa, Beas-Zarate, Carlos, Olloquequi, Jordi, Auladell, Carme, Folch, Jaume, Camins, Antoni

“…Epigallocatechin-3-gallate (EGCG), a catechin found in green tea, has been previously investigated for its neuroprotective effects in vitro and in vivo . In…”
Get full text

From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer's Disease by Olloquequi, Jordi, Díaz-Peña, Roberto, Verdaguer, Ester, Ettcheto, Miren, Auladell, Carme, Camins, Antoni

“…Air pollution, a growing concern for public health, has been linked to various respiratory and cardiovascular diseases. Emerging evidence also suggests a link…”
Get full text

State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections by Cano, Amanda, Ettcheto, Miren, Espina, Marta, López-Machado, Ana, Cajal, Yolanda, Rabanal, Francesc, Sánchez-López, Elena, Camins, Antonio, García, Maria Luisa, Souto, Eliana B

“…Infectious diseases kill over 17 million people a year, among which bacterial infections stand out. From all the bacterial infections, tuberculosis, diarrhoea,…”
Get full text

ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker by Manzine, Patricia Regina, Ettcheto, Miren, Cano, Amanda, Busquets, Oriol, Marcello, Elena, Pelucchi, Silvia, Di Luca, Monica, Endres, Kristina, Olloquequi, Jordi, Camins, Antoni, Cominetti, Márcia Regina

“…[Display omitted] •APP cleavage by the α-secretase ADAM10 releases the soluble portion sAβPPα and prevents the generation of senile plaques.•Non-amyloidogenic…”
Get full text

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment by Poor, Saghar Rabiei, Ettcheto, Miren, Cano, Amanda, Sanchez-Lopez, Elena, Manzine, Patricia Regina, Olloquequi, Jordi, Camins, Antoni, Javan, Mohammad

“…Alzheimer’s disease (AD) is one of the most devastating brain disorders. Currently, there are no effective treatments to stop the disease progression and it is…”
Get full text

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease by Rabieipoor, Saghar, Zare, Meysam, Ettcheto, Miren, Camins, Antoni, Javan, Mohammad

“…Metformin has been introduced as a neuroprotective agent in recent years. Here we evaluate the therapeutic effects of metformin in sporadic mouse model of…”
Get full text

Lipid Nanoparticles for the Posterior Eye Segment by Bonilla, Lorena, Espina, Marta, Severino, Patricia, Cano, Amanda, Ettcheto, Miren, Camins, Antoni, García, Maria Luisa, Souto, Eliana B, Sánchez-López, Elena

“…This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective…”
Get full text

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment by Olloquequi, Jordi, Ettcheto, Miren, Cano, Amanda, Fortuna, Ana, Bicker, Joana, Sánchez-Lopez, Elena, Paz, Cristian, Ureña, Jesús, Verdaguer, Ester, Auladell, Carme, Camins, Antoni

“…Licochalcone A (Lico-A) is a flavonoid compound derived from the root of the Glycyrrhiza species, a plant commonly used in traditional Chinese medicine. While…”
Get full text

Epilepsy in neurodegenerative diseases: related drugs and molecular pathways by Cano, Amanda, Fonseca, Elena, Ettcheto, Miren, Sánchez-López, Elena, de Rojas, Itziar, Alonso-Lana, Silvia, Morató, Xavier, Souto, Eliana B., Toledo, Manuel, Boada, Mercè, Marquié, Marta, Ruíz, Agustín

“…Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological…”
Get full text

Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice by Ettcheto, Miren, Petrov, Dmitry, Pedrós, Ignacio, Alva, Norma, Carbonell, Teresa, Beas-Zarate, Carlos, Pallas, Merce, Auladell, Carme, Folch, Jaume, Camins, Antoni

“…Alzheimer's disease (AD) is currently an incurable aging-related neurodegenerative disorder. Recent studies give support to the hypotheses that AD should be…”
Get more information

Effects of a High-Fat Diet on Insulin-Related miRNAs in Plasma and Brain Tissue in APPSwe/PS1dE9 and Wild-Type C57BL/6J Mice by Rojas-Criollo, Melina, Novau-Ferré, Nil, Gutierrez-Tordera, Laia, Ettcheto, Miren, Folch, Jaume, Papandreou, Christopher, Panisello, Laura, Cano, Amanda, Mostafa, Hamza, Mateu-Fabregat, Javier, Carrasco, Marina, Camins, Antoni, Bulló, Mònica

“…Insulin resistance (IR)-related miRNAs have been associated with the development and progression of Alzheimer’s disease (AD). The dietary modulation of these…”
Get full text